XML 18 R96.htm IDEA: XBRL DOCUMENT v3.19.3
Financial Information for the Company and Its Subsidiaries - Summary of Condensed Consolidating Statement of Cash Flows (Detail) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Operating activities:        
Net income (loss) $ 42,723 $ 46,279 $ 120,435 $ 156,043
Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities:        
Depreciation and amortization 40,620 39,659 122,277 119,360
Amortization of debt issuance costs     8,926 7,763
Equity-based compensation expense 4,039 5,225 14,322 19,273
Deferred income taxes     5,150 (1,738)
Debt extinguishment costs       940
Other     4,444 3,025
Change in operating assets and liabilities:        
Accounts receivable, net     (32,956) (43,252)
Other current assets     (3,912) 3,021
Other assets     530 3,868
Accounts payable and other accrued liabilities     (35,610) 9,230
Accrued salaries and benefits     4,813 11,049
Other liabilities     5,110 149
Net cash provided by continuing operating activities     213,529 288,731
Net cash used in discontinued operating activities       (2,548)
Net cash provided by operating activities     213,529 286,183
Investing activities:        
Cash paid for acquisitions, net of cash acquired     (44,900)  
Cash paid for capital expenditures     (202,722) (249,989)
Cash paid for real estate acquisitions     (6,976) (9,391)
Settlement of foreign currency derivatives     105,008  
Other     12,398 (3,114)
Net cash used in investing activities     (137,192) (262,494)
Financing activities:        
Borrowings on revolving credit facility     76,573  
Principal payments on revolving credit facility     (76,573)  
Principal payments on long-term debt     (24,738) (31,492)
Common stock withheld for minimum statutory taxes, net     (1,498) (2,272)
Other     (5,923) (6,973)
Net cash used in financing activities     (32,159) (40,737)
Effect of exchange rate changes on cash     (1,788) (1,314)
Net increase (decrease) in cash and cash equivalents     42,390 (18,362)
Cash and cash equivalents at beginning of the period     50,510 67,290
Cash and cash equivalents at end of the period 92,900 48,928 92,900 48,928
Consolidating Adjustments [Member]        
Operating activities:        
Net income (loss) (60,296) (62,854) (174,337) (206,204)
Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities:        
Equity in earnings of subsidiaries 60,296 62,854 174,337 206,204
Change in operating assets and liabilities:        
Other assets     (3,847) (4,596)
Net cash provided by continuing operating activities       (4,596)
Net cash provided by operating activities     (3,847) (4,596)
Financing activities:        
Principal payments on long-term debt     3,847 4,596
Net cash used in financing activities     3,847 4,596
Parent [Member]        
Operating activities:        
Net income (loss) 42,723 46,279 120,435 156,043
Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities:        
Equity in earnings of subsidiaries (60,296) (62,854) (174,337) (206,204)
Amortization of debt issuance costs     8,926 8,065
Equity-based compensation expense     14,322 19,273
Deferred income taxes     (158) 74
Debt extinguishment costs       940
Other     2,606 1,948
Change in operating assets and liabilities:        
Other assets     3,847 4,596
Net cash provided by continuing operating activities       (15,265)
Net cash provided by operating activities     (24,359) (15,265)
Investing activities:        
Settlement of foreign currency derivatives     105,008  
Net cash used in investing activities     105,008  
Financing activities:        
Borrowings on revolving credit facility     76,573  
Principal payments on revolving credit facility     (76,573)  
Principal payments on long-term debt     (24,738) (31,492)
Common stock withheld for minimum statutory taxes, net     (1,498) (2,272)
Other     (2,375) (1,742)
Cash (used in) provided by intercompany activity     (52,038) 50,771
Net cash used in financing activities     (80,649) 15,265
Combined Subsidiary Guarantors [Member]        
Operating activities:        
Net income (loss) 37,746 49,389 102,733 142,847
Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities:        
Depreciation and amortization 20,588 18,857 60,210 55,640
Deferred income taxes     4,517 (2,398)
Other     1,643 1,219
Change in operating assets and liabilities:        
Accounts receivable, net     (28,918) (39,644)
Other current assets     (2,845) 7,898
Other assets     (1,136) 3,763
Accounts payable and other accrued liabilities     (29,543) 7,835
Accrued salaries and benefits     2,008 11,100
Other liabilities     16,058 4,548
Net cash provided by continuing operating activities       192,808
Net cash used in discontinued operating activities       (2,548)
Net cash provided by operating activities     124,727 190,260
Investing activities:        
Cash paid for acquisitions, net of cash acquired     (44,900)  
Cash paid for capital expenditures     (135,242) (149,402)
Cash paid for real estate acquisitions     (6,976) (9,391)
Other     7,615 (5,718)
Net cash used in investing activities     (179,503) (164,511)
Financing activities:        
Principal payments on long-term debt       (169)
Other     (1,580) (2,885)
Cash (used in) provided by intercompany activity     86,951 (37,257)
Net cash used in financing activities     85,371 (40,311)
Net increase (decrease) in cash and cash equivalents     30,595 (14,562)
Cash and cash equivalents at beginning of the period     32,471 46,860
Cash and cash equivalents at end of the period 63,066 32,298 63,066 32,298
Combined Non-Guarantors [Member]        
Operating activities:        
Net income (loss) 22,550 13,465 71,604 63,357
Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities:        
Depreciation and amortization 20,032 20,802 62,067 63,720
Amortization of debt issuance costs       (302)
Deferred income taxes     791 586
Other     195 (142)
Change in operating assets and liabilities:        
Accounts receivable, net     (4,038) (3,608)
Other current assets     (1,067) (4,877)
Other assets     1,666 105
Accounts payable and other accrued liabilities     (6,067) 1,395
Accrued salaries and benefits     2,805 (51)
Other liabilities     (10,948) (4,399)
Net cash provided by continuing operating activities       115,784
Net cash provided by operating activities     117,008 115,784
Investing activities:        
Cash paid for capital expenditures     (67,480) (100,587)
Other     4,783 2,604
Net cash used in investing activities     (62,697) (97,983)
Financing activities:        
Principal payments on long-term debt     (3,847) (4,427)
Other     (1,968) (2,346)
Cash (used in) provided by intercompany activity     (34,913) (13,514)
Net cash used in financing activities     (40,728) (20,287)
Effect of exchange rate changes on cash     (1,788) (1,314)
Net increase (decrease) in cash and cash equivalents     11,795 (3,800)
Cash and cash equivalents at beginning of the period     18,039 20,430
Cash and cash equivalents at end of the period $ 29,834 $ 16,630 $ 29,834 $ 16,630